Why the study?
Does pulsatile perfusion improve endocrine system stability compared to nonpulsatile perfusion in patients undergoing heart surgery?
Does pulsatile perfusion improve endocrine system stability compared to nonpulsatile perfusion in patients undergoing heart surgery?
Pulsatile perfusion during cardiopulmonary bypass may help stabilize glucose and certain hormone levels compared to nonpulsatile perfusion.
Answers are grounded in this paper and cite their sources.
Pulsatile perfusion may stabilize endocrine markers during bypass; leaves open outcome benefits in cardiac surgery.
The effects of cardiopulmonary bypass on the endocrine system were investigated in 10 patients who had pulsatile perfusion and in another 10 who had nonpulsatile perfusion during coronary bypass or valve replacement surgery. Measurements were made of thyroid-stimulating hormone, free and total triiodothyronine, free and total tetraiodothyronine, adrenocorticotropic hormone, cortisol, aldosterone, growth hormone, insulin, and glucose at 5 fixed time intervals up to 24 hours postoperatively. In the perfusion period, free and total triiodothyronine levels were less depressed in the pulsatile group. The mean level of growth hormone was significantly higher in the pulsatile group after 60 minutes of perfusion. The mean levels of insulin and glucose were significantly lower in the pulsatile group after 60 minutes of perfusion. Other changes were not statistically significant. We concluded that pulsatile perfusion was of benefit in stabilizing glucose and some hormone levels.
No takes yet. Share an insight, caveat, or question.
Silistreli et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: